Hospital Bribery Continues In Asia Despite Increased Enforcement
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The use of bribery as a standard business practice in Asia remains a concern for pharma industry observers, despite the fact that more countries are actively enforcing international anti-bribery conventions